CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: Are they enough?

Research output: Contribution to journalLetter

Original languageEnglish
Article number49
JournalBreast Cancer Research
Volume21
Issue number1
DOIs
Publication statusPublished - Apr 3 2019

Keywords

  • Breast cancer
  • CD163
  • CD68
  • Matrix metalloproteinase 9
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this